MarketPeel
Insider Trading Intelligence
Pricing
…
PB

Patrick Burnett

ARQT
SEE REMARKS · ARCUTIS BIOTHERAPEUTICS, INC. · CIK 0001741987
FILING MIX · LIFETIME34%/66%
BUYS
33
SELLS
63
TOTAL VALUE
$5.50M
COMPANIES
2
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
175,244
AVG SELL PX
$13.63
TRADE KIND
SHOWING 96 / 96
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
48 backtested trades · 8 horizons · 65 pending
Forward-return performance of every backtestable P/S trade by Patrick Burnett, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d48+41.67%+1.44%+0.50%+0.94%+0.88%0.58
14d48+43.75%+2.56%+0.86%+1.77%+0.68%0.88
30d48+47.92%+6.90%+1.39%+5.84%+1.87%1.74
60d48(1 pending)+40.43%+11.46%+2.15%+9.32%+2.83%1.54
90d48(2 pending)+43.48%+8.16%+4.05%+5.09%+1.60%0.79
180d48(6 pending)+33.33%+27.56%+9.73%+17.83%+10.61%2.60
1y48(20 pending)+17.86%+72.06%+19.30%+52.76%+37.15%—
2y48(36 pending)+33.33%+125.68%+45.98%+75.12%+10.90%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ARQT · 120,244 shares · as of May 11, 2026
080,000160,000240,000320,000202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 33 buys / 63 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
222$21.05$4.7K120,244May 11, 2026May 13, 2026 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
684$23.61$16.1K120,466May 4, 2026May 6, 2026 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
181$25.91$4.7K121,150Mar 2, 2026Mar 3, 2026 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,106$25.16$153.6K121,295Mar 2, 2026Mar 3, 2026 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
77,000——77,000Feb 27, 2026Mar 3, 2026 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,000——127,401Feb 27, 2026Mar 3, 2026 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
9,794$25.81$252.7K80,651Feb 4, 2026Feb 4, 2026 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,675$25.50$93.7K90,445Feb 2, 2026Feb 4, 2026 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,490$28.98$72.2K94,120Jan 5, 2026Jan 7, 2026 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
541$28.81$15.6K97,766Dec 31, 2025Jan 2, 2026 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,156$29.39$34.0K96,610Dec 31, 2025Jan 2, 2026 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
See Remarks
11,500$3.64$41.9K109,807Dec 15, 2025Dec 17, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
11,500$28.94$332.9K98,307Dec 15, 2025Dec 17, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
11,500——143,750Dec 15, 2025Dec 17, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
17,250$24.18$417.1K98,325Nov 6, 2025Nov 10, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
17,250——155,250Nov 6, 2025Nov 10, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
See Remarks
17,250$3.64$62.8K115,575Nov 6, 2025Nov 10, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,864$23.72$91.6K98,325Nov 5, 2025Nov 5, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,607$24.71$64.4K102,204Nov 3, 2025Nov 5, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
15$25.40$381102,189Nov 3, 2025Nov 5, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,438$15.57$38.0K104,811Aug 21, 2025Aug 21, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,750$16.16$28.3K107,249Aug 19, 2025Aug 21, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,847$14.03$54.0K108,999Aug 8, 2025Aug 12, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,622$14.33$37.6K112,846Aug 4, 2025Aug 5, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,750$15.07$86.7K115,468Jul 14, 2025Jul 14, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
See Remarks
5,750——121,218Jul 14, 2025Jul 14, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
5,750——172,500Jul 14, 2025Jul 14, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
See Remarks
23,000——138,468Jul 10, 2025Jul 14, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
23,000——178,250Jul 10, 2025Jul 14, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
23,000$15.05$346.0K115,468Jul 10, 2025Jul 14, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,871$13.59$52.6K115,468May 8, 2025May 9, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,597$15.19$39.4K119,339May 2, 2025May 5, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
12,242$15.04$184.1K121,936Mar 14, 2025Mar 17, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
12,242——201,250Mar 14, 2025Mar 17, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
See Remarks
12,242——134,178Mar 14, 2025Mar 17, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
See Remarks
5,008——126,944Mar 13, 2025Mar 17, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,008$15.10$75.6K121,936Mar 13, 2025Mar 17, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
44,153$14.97$660.8K121,936Mar 13, 2025Mar 17, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
5,008——213,492Mar 13, 2025Mar 17, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
954$13.28$12.7K166,089Mar 4, 2025Mar 4, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,819$13.03$36.7K167,043Mar 3, 2025Mar 4, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
17,000——169,862Feb 28, 2025Mar 4, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
43,000——43,000Feb 28, 2025Mar 4, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
38,000——152,862Feb 28, 2025Mar 4, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
99,000——99,000Feb 28, 2025Mar 4, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
12,116$12.70$153.9K114,862Feb 3, 2025Feb 4, 2025 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,691$14.00$23.7K126,978Dec 31, 2024Dec 31, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
16,023——218,500Nov 22, 2024Nov 26, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
See Remarks
16,023——144,692Nov 22, 2024Nov 26, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
16,023$10.14$162.5K128,669Nov 22, 2024Nov 26, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
See Remarks
100——128,769Nov 15, 2024Nov 18, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
100——234,523Nov 15, 2024Nov 18, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
100$10.03$1.0K128,669Nov 15, 2024Nov 18, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
18,377$10.29$189.2K128,669Nov 14, 2024Nov 18, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
See Remarks
18,377——147,046Nov 14, 2024Nov 18, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
18,377——234,623Nov 14, 2024Nov 18, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
50,749$10.29$522.4K128,669Nov 14, 2024Nov 18, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
15,441$8.68$134.1K179,418Nov 4, 2024Nov 5, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,728$8.29$14.3K194,859Aug 19, 2024Aug 21, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
13,206$9.02$119.1K196,587Aug 2, 2024Aug 5, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
23,000——253,000May 30, 2024May 31, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
See Remarks
23,000——232,793May 30, 2024May 31, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
23,000$8.75$201.3K209,793May 30, 2024May 31, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
49,952$8.72$435.4K209,793May 29, 2024May 31, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
9,555$8.74$83.5K259,745May 2, 2024May 3, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,782$11.12$53.2K269,300Mar 4, 2024Mar 6, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
28,800——0Feb 13, 2024Feb 15, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,600——222,632Feb 13, 2024Feb 15, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
320,000——0Feb 13, 2024Feb 15, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
128,000——213,032Feb 13, 2024Feb 15, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
47,100——0Feb 13, 2024Feb 15, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
23,550——246,182Feb 13, 2024Feb 15, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
27,900——274,082Feb 13, 2024Feb 15, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
55,800——0Feb 13, 2024Feb 15, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
276,000——276,000Jan 12, 2024Jan 17, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
28,000——85,032Jan 12, 2024Jan 17, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
1,325$3.54$4.7K57,032Jan 2, 2024Jan 3, 2024 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
1,305$7.04$9.2K58,357Aug 21, 2023Aug 22, 2023 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
300$7.05$2.1K59,662Aug 21, 2023Aug 22, 2023 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
851$15.26$13.0K59,962Mar 6, 2023Mar 8, 2023 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
1,728$15.82$27.3K39,836Mar 2, 2023Mar 6, 2023 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
23$16.52$38039,813Mar 2, 2023Mar 6, 2023 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
55,800——55,800Mar 2, 2023Mar 6, 2023 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
21,000——60,813Mar 2, 2023Mar 6, 2023 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
1,475$15.01$22.1K41,564Jan 3, 2023Jan 4, 2023 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,750——97,401Aug 18, 2022Mar 3, 2026 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
30$16.44$49343,039Mar 7, 2022Mar 7, 2022 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
See Remarks
981$16.86$16.5K43,069Mar 4, 2022Mar 7, 2022 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
17,800——44,050Mar 3, 2022Mar 7, 2022 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
47,100——47,100Mar 3, 2022Mar 7, 2022 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,750——26,250Dec 30, 2021Jan 4, 2022 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
28,800——28,800Mar 3, 2021Mar 5, 2021 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,500——9,500Mar 3, 2021Mar 5, 2021 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
320,000——320,000Aug 3, 2020Aug 5, 2020 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
33,500——33,500Aug 3, 2020Aug 5, 2020 ↗View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
55,000——55,000Feb 27, 2020Mar 2, 2020 ↗View →
Other insiders · ARQT
Loading peer insiders…
About this filer
CIK 0001741987
ROLE
See Remarks
PRIMARY
ARQT
COMPANIES
2
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001741987DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback